True extended haplotypes of p53: Indicators of breast cancer risk

被引：0
|
作者：
Weston, A [1 ]
Wolff, MS
Morabia, A
机构：
[1] CDC, NIOSH, Hlth Effects Lab Div, Morgantown, WV USA
[2] Mt Sinai Med Ctr, New York, NY 10029 USA
[3] Hop Cantonal Geneva, Dept Med Commun, Div Clin Epidemiol, CH-1211 Geneve, Switzerland
来源：
CANCER GENETICS AND CYTOGENETICS | 1998年 / 102卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：153 / 154
页数：2
相关论文
共 50 条
  • [31] p53 in breast cancer: mutation and countermeasures
    Kumar, Sumit
    Walia, Vijay
    Ray, Maria
    Elble, Randolph C.
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2007, 12 : 4168 - 4178
  • [32] p53 haplotype determination in breast cancer
    Weston, A
    Pan, CF
    Ksieski, HB
    Wallenstein, S
    Berkowitz, GS
    Tartter, PI
    Bleiweiss, IJ
    Brower, ST
    Senie, TR
    Wolff, MS
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 1997, 6 (02) : 105 - 112
  • [33] Overexpression of p53 in human breast cancer
    Minguillon, C
    Heinze, T
    Schönborn, I
    Lichtenegger, W
    JOURNAL OF TUMOR MARKER ONCOLOGY, 1999, 14 (01): : 13 - 17
  • [34] P53 EXPRESSION IN BREAST-CANCER
    CATTORETTI, G
    RILKE, F
    ANDREOLA, S
    DAMATO, L
    DELIA, D
    INTERNATIONAL JOURNAL OF CANCER, 1988, 41 (02) : 178 - 183
  • [35] P53 MUTATIONS IN BREAST-CANCER
    COLES, C
    CONDIE, A
    CHETTY, U
    STEEL, CM
    EVANS, HJ
    PROSSER, J
    CANCER RESEARCH, 1992, 52 (19) : 5291 - 5298
  • [36] Serum p53 antibody in breast cancer
    Yamamoto, Shinya
    Chishima, Takashi
    Adachi, Shouko
    Harada, Fumi
    Toda, Youko
    Arioka, Hitoshi
    Hasegawa, Naoki
    Kakuta, Yukio
    CANCER BIOMARKERS, 2014, 14 (04) : 203 - 206
  • [37] p53 polymorphism in ovarian and breast cancer
    Campbell, IG
    Eccles, DM
    Dunn, B
    Davis, M
    Leake, V
    LANCET, 1996, 347 (8998): : 393 - 394
  • [38] p53 as a mutagen test in breast cancer
    Hill, KA
    Sommer, SS
    ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2002, 39 (2-3) : 216 - 227
  • [39] Expression of p53 Protein in Premenopausal Women as Risk Factors for Breast Cancer
    Rashidah, S.
    Rashmizal, Hairil A. R.
    Ho, S. E.
    Mazlina, Wan M. S.
    MEDICINE AND HEALTH-KUALA LUMPUR, 2016, 11 (02): : 189 - 198
  • [40] THE ASSOCIATION OF P53 IMMUNOPOSITIVITY WITH TUMOR PROLIFERATION AND OTHER PROGNOSTIC INDICATORS IN BREAST-CANCER
    BHARGAVA, V
    THOR, A
    DENG, GR
    LJUNG, BM
    MOORE, DH
    WALDMAN, F
    BENZ, C
    GOODSON, W
    CHEW, K
    SMITH, HS
    MODERN PATHOLOGY, 1994, 7 (03) : 361 - 368
12345